Status: Approved
Entry Type: Unknown
Molecule Category: UNKNOWN

Indications

Mesh Heading Maximum Phase Reference
Multiple Sclerosis; Sclerosis Phase 1/Phase 2 ClinicalTrials
Diabetes Mellitus, Type 2; Insulin Resistance; Metabolic Syndrome Phase 1/Phase 2 ClinicalTrials
Alzheimer Disease Phase 3 ClinicalTrials
Fetal Growth Retardation Phase 2 ClinicalTrials
Cognitive Dysfunction; Memory Disorders Phase 3 ClinicalTrials
Breast Neoplasms; Neurotoxicity Syndromes Phase 3 ClinicalTrials
Alzheimer Disease; Cognition Disorders Phase 4 ClinicalTrials
Multiple Sclerosis; Sclerosis Phase 2 ClinicalTrials
Sexual Dysfunctions, Psychological Phase 2 ClinicalTrials
Cognitive Dysfunction Phase 4 ClinicalTrials
Glaucoma; Glaucoma, Open-Angle Phase 2 ClinicalTrials
Neuritis; Vestibular Neuronitis Phase 3 ClinicalTrials
CONTENTS